Not Applicable.

Uses and Use Restrictions

Applicants must adhere to all CDC guidelines regarding allowable and unallowable expenses. Maintain and enhance a viable and functional CKD Surveillance System website.

www.cdc.gov/ckd/surveillance Increase the visibility of the CKD Surveillance System and disseminate the CKD surveillance findings by the number of publications and related citations in peer-reviewed journals and presentations at national and international meetings and conferences.

Improve the breadth and scope of CKD surveillance data in the United States by the number of established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to CKD surveillance. Expand and grow the CKD Surveillance System by the number of CKD topics and indicators focusing on CKD burden and health consequences, risk factors, at-risk or vulnerable populations, and geographic indicators with up-to-date data and trends.

Assess and evaluate the CKD Surveillance System content, data sources to keep or include, gaps in surveillance data, and future data and research needs.

Provide data analysis reports for HP2020 progress review in achieving CKD objectives.

Restrictions, which must be taken into account while writing the budget, are as follows: ?Recipients may not use funds for research. ?Recipients may not use funds for clinical care. ?Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. ?Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment.

Any such proposed spending must be identified in the budget. ?The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. ?Reimbursement of pre-award costs is not allowed.

Eligibility Requirements

Applicant Eligibility

? Public nonprofit organizations ? Private nonprofit organizations ? For profit organizations ? Small, minority, and women-owned businesses ? Universities ? Colleges ? Research institutions ? Hospitals ? Community-based organizations ? Faith-based organizations ? Indian/Native American Tribal Governments (Federally Recognized) ? Indian/Native American Tribal Governments (other than Federally recognized) ? Indian/Native American Tribally Designated Organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).

Note: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

Beneficiary Eligibility

The general public will benefit from the objectives of this program. Kidney diseases are the ninth leading cause of death in the United States and more than 1 of 10 US adults may have CKD. The CKD Surveillance System is intended to raise awareness about CKD and its risk factors, promote early diagnosis, and improve outcomes for those living with CKD.

Credentials/Documentation

Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures and provide a budget justification of funds requested. Costs for nonprofit recipients will be determined in accordance with HHS Regulations, 45 CFR Part 74, Subpart Q. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is required.

Environmental impact information is not required for this program.

This program is eligible for coverage under E.O.

12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program.

Award Procedures

After review and approval of an application, a notice of award is prepared and processed, along with appropriate notification to the public.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Section 317(k)(2) of the Public Health Service Act (PHS Act), 42 U.S.C. 247b(k)(2), Section 301(a) of the PHS Act, 42 U.S.C. 241(a).

Range of Approval/Disapproval Time

From 120 to 180 days.

Appeals

Not Applicable.

Renewals

From 90 to 120 days. Project periods are for 1 to 5 years with 12-month budget periods contingent on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government. Applications must be obtained from Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. Telephone: (770) 488-2700.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.

Length and Time Phasing of Assistance

12 budget period within a 5 year project period. Method of awarding/releasing assistance: lump sum.

Post Assistance Requirements

Reports

APR are due 120 days before the end of the budget period.

No cash reports are required.

APR are due 120 days before the end of the budget period.

Federal Financial Reports (FFRs) are due 90 days after the end of the budget period.

Provided in the Funding Opportunity Announcement.

Audits

No audits are required for this program.

Records

No Data Available.

Financial Information

Account Identification

75-0943-0-1-550.

Obigations

(Cooperative Agreements) FY 16 $1,198,444; FY 17 est $1,198,444; and FY 18 est $1,198,444 - This CFDA supports a new FOA beginning in FY16.

Range and Average of Financial Assistance

Current FOA DP11-1109 funds three awardee ranging from 200000 ? 400000; new FY16 will fund two range is contingent upon funding request.

Regulations, Guidelines, and Literature

Successful applicants must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) Part 74 or 92 as appropriate.

Information Contacts

Regional or Local Office

None.

Headquarters Office

Nilka Rios-Burrows 4770 Buford Hwy, MS F-75, Atlanta, Georgia 30341 Phone: 7704881057

Criteria for Selecting Proposals

Eligible applicants must be able to demonstrate: Previous experience with the development of large-scale CKD surveillance systems Established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to the CKD surveillance system A proven track record of publications related to the establishment of a national CKD surveillance system and dissemination of surveillance findings. Previous experience with national, regional, and hospital based data pertaining to CKD and its risk factors Previous experience with working in a collaborative multi-center project for the development and maintenance of a national surveillance system.